ASX:AFP

AFT Pharmaceuticals Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive AFP News and Ratings via Email

Sign-up to receive the latest news and ratings for AFT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.


About AFT Pharmaceuticals

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











AFT Pharmaceuticals (ASX:AFP) Frequently Asked Questions

What stocks does MarketBeat like better than AFT Pharmaceuticals?

Wall Street analysts have given AFT Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AFT Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are AFT Pharmaceuticals' key executives?

AFT Pharmaceuticals' management team includes the following people:
  • Dr. Hartley Atkinson, Founder, CEO, MD & Exec. Director
  • Ms. Marree Atkinson, Chief of Staff & Exec. Director
  • Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ, CFO & Company Sec.
  • Mr. Murray Keith, Group Marketing Mang.
  • Ms. Ioana Stanescu, Head of Drug Devel.
  • Mr. Calvin Mackenzie, Gen. Mang. of AFT Australia
  • Mr. Scott Crawford, Gen. Mang. of Promoted Products Australasia & South East Asia
  • Ms. Louise Clayton, Director of International Bus.

Who are some of AFT Pharmaceuticals' key competitors?

Some companies that are related to AFT Pharmaceuticals include 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Ascend Wellness (AWWH), Australian Primary Hemp (APH), Ayr Wellness (AYRWF), BellRock Brands (DXBRF) and Benchmark (BHCCF).
View all of AFP's competitors.

What is AFT Pharmaceuticals' stock symbol?

AFT Pharmaceuticals trades on the ASX under the ticker symbol "AFP."

How much money does AFT Pharmaceuticals make?

AFT Pharmaceuticals has a market capitalization of $0.00 and generates $113.11 million in revenue each year.

How many employees does AFT Pharmaceuticals have?

AFT Pharmaceuticals employs 94 workers across the globe.

What is AFT Pharmaceuticals' official website?

The official website for AFT Pharmaceuticals is www.aftpharm.com.

How can I contact AFT Pharmaceuticals?

The company can be reached via phone at 64 9 488 0232.


This page was last updated on 9/23/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.